Abstract
Relapse in Kala-azar is a common problem, occurring in 5–30% of patients (Chulay et al, 1983, Sanyal and Arora, 1979). Although this could be attributed to re-infection, there is a strong possibility that it may at least partly be due to treatment failure. Two recent studies suggest that removal of parasites from certain tissue sites may be difficult.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adinolfi, L.E., Bonventre, P.F., Vander Pas, M. and Eppstein, D.A. (1985) Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis. Infect. and Immun., 48:409.
Alving, C.R. (1986) Liposomes as drug carriers in leishmaniasis and malaria. Parasit. Today, 2:101.
Anabwani, G.M., Ngira, J.A., Dimiti, G. and Bryceson, A.D.M. (1983) Comparison of two dosage schedules of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. Lancet, 29 July, 1983, 211.
Baillie, A.J., Florence, A.T., Hume, L.R., Muirhead, G.T. and Rogerson, A. (1985) The preparation and properties of niosomes — non-ionic surfactant vesicles. J. Pharm.Pharmacol., 37:863.
Baillie, A.J., Coombs, G.H., Dolan, T.F. and Laurie, J. (1986) Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-1eishmanial drug, sodium stibogluconate. J.Pharm.Pharmacol., 38:502.
Black, C.D.V., Watson, G.J. and Ward, R.J. (1977) The use of pentostam liposomes in the chemotherapy of experimental leishmaniasis. Trans.Royal Soc.Trop.Med.Hyg., 71:550.
Blackwell, J.M., Freeman, J.C. and Bradley D.J. (1980) Influence of the H-2 complex on acquired resistance to Leishmania donovani infection in mice. Nature, 283:72.
Bradley, D.J. and Kirkley, J. (1977) Regulation of Leishmania populations within the host. 1. The variable course of Leishmania donovani infections in mice. Clin.Exp.Immunol., 30:119.
Carter, K.C., Baillie, A.J., Alexander, J. and Dolan, T.F. (1987) submitted J. Pharm.Pharmacol. The therapeutic effect of sodium stibogluconate in BALB/c mice infected with L. donovani is organ dependent.
Chulay, J.D., Bhatt, S.M., Muigai, R., Ho, M., Gochihi, G., Were, J.B., Chunge, C. and Bryceson, A.D. (1983) A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. J. Infect. Dis., 148:148.
Koech, D.K. (1987) Subpopulations of T. lymphocytes in Kenyan patients with visceral leishmaniasis. Am.J.Trop.Med.Hyg., 36:497.
Manson-Bahr, P.E.C. (1959) East African kala-azar with special reference to the pathology, prophylaxis and treatment. Trans.Roy.Soc.Trop.Med.Hyg., 53:123.
Napier, L.E. (1946) in “The Principles and Practice of Tropical Medicine”, p.134, Macmillan, New York.
Sacks, D.L., Lai, S.L., Shrivastava, S.N., Blackwell, J. and Neva, F.A. (1987) An analysis of T cell responsiveness in Indian Kala-azar. J.Immunol., 138:908.
Sanyal, R.K. and Arora, R.R. (1979) Assessment of drug therapy of Kala-azar in current epidemic in Bihar.J.Commun.Dis., 11:198.
Ulczak, O.M. and Blackwell, J.M. (1983) Immunoregulation of genetically controlled acquired response to Leishmania donovani. Infection if mice: the effects of parasite dose, cyclophosphamide and sublethal irradiation. Parasite Immunol., 5:449.
Wickramasinghe, S.N., Abdalla, S.H. and Kaisili, E.G. (1987) Ultrastructure of bone marrow in patients with visceral leishmaniasis. J.Clin.Path., 40:267.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Carter, K.C., Alexander, J., Baillie, A.J., Dolan, T.F. (1989). Relapse in Kala Azar: Failure of Sodium Stibogluconate to Clear Parasites from Organs Other than the Liver. In: Hart, D.T. (eds) Leishmaniasis. NATO ASI Series, vol 171. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1575-9_89
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1575-9_89
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8862-6
Online ISBN: 978-1-4613-1575-9
eBook Packages: Springer Book Archive